Centers and Principal Investigators
Participating in Lung Health Studies I, II, and III:
- Baltimore, Maryland: Johns Hopkins University School Of Medicine, Robert Wise, MD
- Birmingham, Alabama: University of Alabama at Birmingham, William Bailey, MD
- Cleveland, Ohio: Case Western Reserve University, Murray Altose, MD
- Detroit, Michigan: Henry Ford Hospital, Michael Eichenhorn, MD
- Los Angeles, California: University of California - Los Angeles, Donald Tashkin, MD
- Pittsburgh, Pennsylvania: University at Pittsburgh, Gregory Owens, MD / Robert Rogers, MD
- Portland, Oregon: Oregon Health Sciences University, A. Sonia Buist, MD
- Rochester, Minnesota: Mayo Clinic , Paul Scanlon, MD
- Salt Lake City, Utah: University of Utah, Richard Kanner, MD
- Winnipeg, Manitoba: University of Manitoba, Nicholas Anthonisen, MD
- Minneapolis, Minnesota: University of Minnesota (Data Coordinating Center), John E. Connett, PhD
The Lung Health Studies I, II and III are multi-center
clinical trials sponsored by the Division of Lung
Disease of the
National Heart, Lung, and Blood
Institute.
General Officers
- Project Officer, Lung Health Study I: James Kiley, PhD
- Director, Airway Biology and Disease Program, Division of Lung Diseases, National Heart, Lung, and Blood Institute
- Project Officer, Lung Health Study II and III: Gail Weinmann, MD
- Division of Lung Diseases, National Heart, Lung, and Blood Institute
- Chair, Steering Committee: Nicholas Anthonisen, MD
- Dean, Faculty of Medicine, University of Manitoba
If you have questions or comments on Lung Health Study I, II or III, please e-mail (by clicking on his name) Dr. John Connett (john-c@ccbr.umn.edu).
This site designed by
Darrin Lythgoe
Last modified: May 5, 1999